Human Bladder Urothelial Cell Structure and Function in Bladder Hypersensation

膀胱过敏中的人膀胱尿路上皮细胞结构和功能

基本信息

  • 批准号:
    7278843
  • 负责人:
  • 金额:
    $ 32.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The relevance of bladder urothelial cells (BUG) to human disease has traditionally been understood only in terms of urothelial cell carcinoma. However, there is exciting new literature highlighting the role of altered BUG structure and function in non-neoplastic states. Two highly prevalent yet poorly understood conditions, interstitial cystitis (IC) and overactive bladder (OAB) may both be associated with pathogenic changes in the bladder urothelium. Both of these conditions are characterized by hypersensory symptoms such as urinary urgency, frequency, and bladder pain. We propose to study the structure and function of the bladder urothelium as it relates to both normal and hypersensory conditions of IC and OAB. Recent scanning electron microscopy of the lumenal side of the bladder urothelium show distinct changes between IC and control apical umbrella cells (AUC). These changes could be due to abnormalities in uroplakins expression. Uroplakins are unique proteins expressed only by the AUC in the urothelium and play a role in AUC membrane structure and function. Human IC BUC grown in culture also had abnormalities including augmented purinergic signaling, altered expression of certain growth factors (HB-EGF, EGF and APF), and decreased potassium conductance (mediated by ion channels Kir2.1 and BK) leading to depolarization. The discovery of muscarinic M2 receptors on the bladder urothelium provides another mechanism of action in the use of antimuscarinics in treatment of OAB. This grant will test the following 4 hypotheses: 1. AUC from patients with bladder hypersensory conditions have structural abnormalities related to uroplakins. 2. The bladder urothelium from patients with bladder hypersensory conditions have altered protein expressions of tight junction proteins (ZO-1, occludin), Kir2.1, BK, M2, HB-EGF, EGF and APF. 3. The conductance of ion channel Kir2.1 is decreased in IC BUC. This can be reversed with HB-EGF treatment. Normal BUC can be made to have decreased Kir2.1 conductance with APF treatment. 4. The conductance of the BK channel is regulated by M2 receptors in human BUC. There is a decreased outward potassium current in OAB and IC BUC which can be reversed by hSIo cDNA transfection. By accomplishing these aims, we hope to develop an understanding of the pathogenesis of hypersensory bladder conditions which ultimately can lead to targeted treatment options.
描述(由申请人提供):膀胱尿路上皮细胞(BUG)与人类疾病的相关性传统上仅被理解为尿路上皮细胞癌。然而,有令人兴奋的新文献强调了在非肿瘤状态下改变的BUG结构和功能的作用。间质性膀胱炎(IC)和膀胱过度活动症(OAB)这两种高度流行但知之甚少的疾病都可能与膀胱尿路炎的致病性变化有关。这两种疾病的特征是超感觉症状,如尿急,尿频和膀胱疼痛。 我们建议研究膀胱尿路上皮的结构和功能,因为它涉及到IC和OAB的正常和超感觉条件。最近的扫描电子显微镜的膀胱尿路上皮的内腔侧显示IC和控制顶伞细胞(AUC)之间的明显变化。这些变化可能是由于尿斑蛋白表达异常。尿斑蛋白是仅由尿路上皮中的AUC表达的独特蛋白质,并且在AUC膜结构和功能中起作用。在培养物中生长的人IC布克C也具有异常,包括增强的嘌呤能信号传导、改变的某些生长因子(HB-EGF、EGF和APF)的表达和降低的钾电导(由离子通道Kir2.1和BK介导),导致去极化。在膀胱尿路上皮上发现毒蕈碱M2受体为使用抗毒蕈碱药物治疗OAB提供了另一种作用机制。 本研究将检验以下4个假设:1。来自膀胱感觉过敏症患者的AUC具有与尿斑蛋白相关的结构异常。2.膀胱感觉过敏症患者的膀胱尿道炎改变了紧密连接蛋白(ZO-1,occludin)、Kir2.1、BK、M2、HB-EGF、EGF和APF的蛋白表达。3. IC布克中离子通道Kir2.1的电导降低。这种情况可以通过EGF治疗来缓解。通过APF治疗,可以使正常的布克具有降低的Kir2.1电导率。4.在人布克中,BK通道的电导由M2受体调节。OAB和IC布克C的外向钾电流均降低,hSIo cDNA转染可逆转该现象。通过实现这些目标,我们希望了解膀胱感觉过敏症的发病机制,最终可以找到有针对性的治疗方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOBY C CHAI其他文献

TOBY C CHAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOBY C CHAI', 18)}}的其他基金

Urinary Incontinence Treatment Network (UITN)
尿失禁治疗网络 (UITN)
  • 批准号:
    8147970
  • 财政年份:
    2010
  • 资助金额:
    $ 32.46万
  • 项目类别:
Human Bladder Urothelial Cell Structure and Function in Bladder Hypersensation
膀胱过敏中的人膀胱尿路上皮细胞结构和功能
  • 批准号:
    7983871
  • 财政年份:
    2009
  • 资助金额:
    $ 32.46万
  • 项目类别:
Human Bladder Urothelial Cell Structure and Function in Bladder Hypersensation
膀胱过敏中的人膀胱尿路上皮细胞结构和功能
  • 批准号:
    7856568
  • 财政年份:
    2009
  • 资助金额:
    $ 32.46万
  • 项目类别:
Human Bladder Urothelial Cell Structure and Function in Bladder Hypersensation
膀胱过敏中的人膀胱尿路上皮细胞结构和功能
  • 批准号:
    7132750
  • 财政年份:
    2006
  • 资助金额:
    $ 32.46万
  • 项目类别:
Human Bladder Urothelial Cell Structure and Function in Bladder Hypersensation
膀胱过敏中的人膀胱尿路上皮细胞结构和功能
  • 批准号:
    7667240
  • 财政年份:
    2006
  • 资助金额:
    $ 32.46万
  • 项目类别:
Interstilal Cystitis Clinical Research Network
间质性膀胱炎临床研究网络
  • 批准号:
    6947657
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Interstitial Cystitis Clinical Research Network
间质性膀胱炎临床研究网络
  • 批准号:
    6882718
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Interstilal Cystitis Clinical Research Network
间质性膀胱炎临床研究网络
  • 批准号:
    7053688
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Interstilal Cystitis Clinical Research Network
间质性膀胱炎临床研究网络
  • 批准号:
    6794200
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Interstilal Cystitis Clinical Research Network
间质性膀胱炎临床研究网络
  • 批准号:
    7415861
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了